Moderna’s booster is administered as a 50-microgram dose. The drugmaker said the 50-microgram booster increased antibody levels 37-fold, and a 100-microgram booster dose increased antibody levels 83-fold.
As omicron continues to spread rapidly, Moderna said its first priority is to continue producing booster shots of its original vaccine. The drugmaker said it will also continue to develop an omicron-specific booster and expects to begin clinical trials in early 2022.
On Dec. 8, Pfizer said preliminary data showed people who received its booster saw neutralization against the omicron variant similar to whatits two-dose series provided against the original coronavirus strain.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
